(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SIMCYP

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

SIMCYP

ST13

US500000079041699

Class

9, 42

Filing

79041699

Registration

3449804

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

44

Latest update

06/13/2025

Classification

Registered

Trademark type

Combined

Nice classes

9, 42

Filing date

07/12/2007

Registration date

06/17/2008

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/13/2018

Last transaction

06/13/2025

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

5

Owner type

99

Owner location

GB

Examiner

HOLTZ, ALLISON

Law office

M20

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Simcyp Limited

Representatives

Carrie Webb Olson Day Pitney LLP

Technical classification

Nice Classes

Class 9Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Computer softwarecomputer software for the conducting of pharmacokinetic and pharmacodynamic simulations of medicines and their effect on the human bodycomputer software for utilising demographicphysiologicgenomic databases for the creation and development of algorithms allowing researchers to take into account patient variabilitycomputer software for the production of drug effects on a virtual patient populationcomputer software which allows pharmaceutical product developers to identify potential patients and groups of individuals which may be at extreme risk to adverse reaction to particular medicines or combinations; pharmaceutical analysis computer software; computer software that uses in vitro data from human tissues to predict metabolisminteractions and kinetic behaviour of drugs/chemicals in vivo (whole human)

Class 42

Scientific consultancy services in the field of pharmaceutical product developmentpharmaceutical researchpharmaceutical drug research and developmentvirtual testing of new pharmaceutical drugs and products by means of computer simulation; scientific consultancy services employing pharmaceutical analysis software that uses in vitro data from human tissues to predict the metabolisminteractionskinetic behaviour of drugs/chemicals in vivo (whole human)

Publications

History of USPTO decisions and trademark events.

44 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/12/2025

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

07/26/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/26/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

07/26/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/26/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/26/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/26/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/26/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/09/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/09/2019

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

07/13/2018

71AG

REGISTERED-SEC.71 ACCEPTED

07/13/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/10/2018

ES71

TEAS SECTION 71 RECEIVED

06/15/2018

RNWL

INTERNATIONAL REGISTRATION RENEWED

08/17/2017

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

06/17/2017

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/02/2016

NREP

NEW REPRESENTATIVE AT IB RECEIVED

09/11/2015

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

04/28/2014

C75A

REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.

04/28/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/28/2014

715F

REGISTERED - SEC. 71 & SEC. 15 FILED

03/19/2014

ES75

TEAS SECTION 71 & 15 RECEIVED

03/19/2014

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

12/31/2012

FICS

FINAL DISPOSITION NOTICE SENT TO IB

10/06/2008

FIMP

FINAL DISPOSITION PROCESSED

10/06/2008

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/17/2008

R.PR

REGISTERED-PRINCIPAL REGISTER

06/17/2008

PUBO

PUBLISHED FOR OPPOSITION

04/01/2008

NPUB

NOTICE OF PUBLICATION

03/12/2008

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/26/2008

ALIE

ASSIGNED TO LIE

02/26/2008

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/29/2008

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/08/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/08/2008

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/08/2008

RFNT

REFUSAL PROCESSED BY IB

11/25/2007

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/26/2007

RFRR

REFUSAL PROCESSED BY MPU

10/25/2007

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/25/2007

CNRT

NON-FINAL ACTION WRITTEN

10/24/2007

DOCK

ASSIGNED TO EXAMINER

10/17/2007

NWAP

NEW APPLICATION ENTERED

09/07/2007

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

09/06/2007

Continuous trademark protection

Get notified about every new filing that threatens SIMCYP or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.